INHIBITION OF ANTIPLASMIN, AND FIBRINOLYTIC EFFECT OF PROTEASE IN PATIENTS WITH CANCER
- 27 January 1968
- journal article
- Published by Elsevier in The Lancet
- Vol. 291 (7535) , 173-176
- https://doi.org/10.1016/s0140-6736(68)92564-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The physiology of fibrinolysisIrish Journal of Medical Science, 1967
- THE EVALUATION IN THE DOG OF A PROTEOLYTIC ENZYME DERIVED FROM ASPERGILLUS ORYZAECanadian Journal of Physiology and Pharmacology, 1964
- The coagulative factors of normal human and human cancer tissueIrish Journal of Medical Science, 1963
- The Proteolytic Enzymes of Aspergillus oryzae. I. Methods for the Estimation and Isolation of the Proteolytic Enzymes.Acta Chemica Scandinavica, 1963
- The Proteolytic Enzymes of Aspergillus oryzae. IV. On the Inhibition of the Enzymes by Serum.Acta Chemica Scandinavica, 1962
- Some properties of the cancer coagulative factorIrish Journal of Medical Science, 1961
- PURIFICATION OF ASPERGILLIN OThe Lancet, 1959
- Fibrinolysis. I. Fibrinolytic Activity of Extracts from non-Pathogenic fungi.Experimental Biology and Medicine, 1958
- Classification of Proteolytic Enzymes by Means of their InhibitorsNature, 1952
- Preparation of Crystals Containing Protease from Aspergillus oryzæNature, 1950